Abstract
Abstract TIM-4 is a member of the T cell immunoglobubulin mucin (TIM) family and is expressed on macrophage and dendritic cell populations. TIM-4 specifically binds phosphatidylserine (PtdSer) on the surface of apoptotic cells and mediates phagocytosis of apoptotic cells by macrophages. NIH3T3 cells transfected with TIM-4 can phagocytose apoptotic thymocytes and this phagocytosis can be blocked by PtdSer liposomes, indicating that TIM-4 is sufficient to mediate phagocytosis of apoptotic cells in a PtdSer-dependent manner. We examined cytokine secretion by mouse peritoneal macrophage after phagocytosis of apoptotic thymocytes and found that production of a set of cytokines including TGF-β, IL-10, and others was increased dramatically. We performed qRT-PCR assays to detect the mRNA level of these cytokines upon peritoneal macrophage phagocytosis of apoptotic thymocytes. We found that the increased cytokine mRNA levels peaked from 30 minutes to 3 hours and protein production peaked at 24h. The anti-mouse TIM-4 antibody, 21H12, can block TIM-4 recognition of PtdSer and reduce phagocytosis of apoptotic cells by peritoneal macrophages. The 21H12 antibody effectively suppressed the cytokine mRNAs induced by TIM-4-mediated phagocytosis of apoptotic cells. These findings indicate that TIM-4 plays an important role in phagocytosis of apoptotic cells and secretion of regulatory cytokines by mouse peritoneal macrophages and may play an important role in immune regulation through these cytokines.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.